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1. Introduction
Analytic method development and validation are key elements of any pharmaceutical development program. HPLC 
analysis method is developed to identify, quantity or purifying compounds of interest. This technical brief will focus on  
development and validation activities as applied to drug products.  Method validation is the process of proving that  an  
analytical  method  is  acceptable  for  its  intended  purpose1.  The  parameters  for  method  validation  as  defined  by  ICH 
(International Conference on Harmonization) guidelines are Accuracy, Precision, Specificity, Limit of Detection,  Limit of 
Quantitation, Linearity, Range, Robustness, Ruggedness. The purpose of the stability studies is to ascertain how the quality 
of a medicinal product varies as a function of time and under the influence of a variety of environmental factors. The ICH 
guidelines ‘Stability testing of new drug substances and products ‘ (QIA) requires that stress testing should be carried out to 
elucidate the substance. It  suggests that  the degradation product that  are formed under the variety of condition should 
include the effect of temperature, humidity where appropriate, oxidation, photolysis and susceptibility to hydrolysis across a 
wide range of pH value. The study of the effect  of temperature is  suggested to be done in 10oC increment above the 
accelerated temperature test condition (e.g. 50oC, 60oC etc.) and that of humidity at a level of 75 % or greater. No details 
are however provided for the study of oxidation, photolysis and hydrolysis at different pH values2-4. Tapentadol [Figure1] is 
chemically 3-[(1R, 2R)-3-(dimethyl amino)-1-ethyl-2-methylpropyl] phenol hydrochloride. It is a centrally-acting, oral µ-
opioid receptor agonist which also inhibits norepinephrine and serotonin reuptake within the CNS. It is used in metastatic  
bone cancer,  postsurgical  dental pain,  painful  diabetic nephropathy.  It  is  Freely Soluble in water,  0.1N HCl, simulated 
intestinal fluid and at controlled room temp (22 0C, 77 0 F) protected from moisture. 5,6 Paracetamol[Figure2] is chemicaly 
4-Hydroxyacetanilide.  It  is  used  as  Analgesic  and  Antipyretic.  It  is  insoluble  in  water,  very soluble  in  ethanol. 7-9 In 
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literature, many analytical methods have been reported for estimations of  Tapentadol And Paracetamol individually from 
biological fluids.10-14 Therefore, the present aim was undertaken to develop simple, accurate, precise and rapid and RP-
HPLC method for determination TAP and PARA in a combined dosage form .
          Figure 1 : Structure of Tapentadol                                                Figure 2 : Structure of Paracetamol
                                                                                                       
 
2. Methods and Materials
2.1 Chemicals and reagents: All the solvents and chemicals used were of HPLC and analytical grade. Mili Q water and 
0.45 µm Teflon filter was used throughout the experimental work. The gift drug samples of TAP and PARA were provided  
by  Glenmark  R  & D,  Sinnar.  The  tablet  formulation  of  TAP &  PARA (Vorth  TP Plus,  Manufactured  by  Glenmark 
Pharmaceuticals ) was purchased from the market . Chemicals and Reagents Used are Hydrogen Peroxide 30%, Ortho-
Phosphoric  acid,  Concentrated  Hydrochloric  Acid,  Potassium Dihydrogen  Orthophosphate,  Sodium Hydroxide  Pellets, 
Acetonitrile, Water, Methanol, Triethylamine.
2.2 Instrument: The chromatographic separation performed using Waters HPLC System with PDA detector, model 2996. 
Software used to monitor was Empower Pro and Quaternary pump is applied. Analytical balance is used, Make Sartorious  
(Model AB - 20.04). pH meter was also used, Labindia Make, Model pH System 362.
2.3 Preparation of  mobile phase:  The dilution was prepared by mixing Buffer  solution, ACN & MeOH in the ratio 
(75:20:05 v/v), degas it with ultrasonic bath & use.
2.4 Preparation of diluent: The dilution was prepared by mixing Buffer solution, ACN & MeOH in the ratio of (50:40:10 
v/v), degas it with ultrasonic bath & use.
2.5 Preparation of buffer (0.025 m): Dissolve 1.36 gm of monobasic KH2PO4 in 100.0 mL of water, and add 1.0 mL of 
TEA, adjust pH to 3.0 with dilute OPA. Filter it through nylon membrane filter of 0.45 µm.
2.6 Selection of analytical wavelength: The absorbance of TAP (20.0 µg/mL) and PARA (130.0 µg/mL) solutions were 
found highest at 220 nm. Therefore, 220 nm was selected as a wavelength for the estimation of drugs. The Overlain Spectra  
of TAP &PARA was recorded and shown in the figure 3.
Figure 3 : Overlain Spectra of TAP &PARA
2.7 Analysis of physical laboratory mixture
2.7.1 Preparation of standard stock solution A: Weigh accurately 29.11 mg of TAP HCl working standard (equivalent to 
25.0 mg of TAP) and transfer it into 100.0 mL dry volumetric flask, add 70.0 mL of diluent, keep the flask in ultrasonic bath 
for 5 Min to dissolve the drug completely and make up the volume with diluent. (Conc. of TAP is 250.0 µg/mL) 
2.7.2 Preparation of standard stock solution B: Weigh accurately 65.0 mg of PARA working standard and transfer it into 
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100.0 mL dry volumetric flask, add 70.0 mL of diluent, keep the flask in ultrasonic bath for 5 Min to dissolve the drug 
completely and make up the volume with diluent. (Conc. of PARA is 650.0 µg/mL) 
2.7.3 Mix standard solution: Pipette out 4.0 mL of solution A & 10.0 mL of solution B into 50.0 mL volumetric flask & 
make up the volume with water. (Conc. of TAP is 20.0 µg/mL and Conc. of PARA is 130.0 µg/mL).
2.7.4 Preparation of sample solution: Weigh accurately 29.11 mg of TAP HCl (equivalent to 25.0 mg of TAP) & 65.0 mg 
of PARA into 500.0 mL volumetric flask add 70.0 mL of diluent, shake it vigorously to dissolve the drug completely and 
make up the volume with diluent. It was further diluted to get concentration of 20 µg/mL of TAP and 130 µg/mL of PARA.  
The peak area of standard laboratory mixture and sample laboratory mixture was compared to obtain the concentration. The 
amount of each drug estimated in laboratory mixture was calculated using following formula-
                                           At          Ds        Ws
 % Estimation =             -------- x-------- x--------- x 100  
                                           As          Dt        Wt
 Where,
 At = Area count for sample solution; As = Area count for standard solution; Ds = Dilution factor for standard; Dt= Dilution 
factor for sample; Ws = Weight of standard (mg); Wt= Weight of sample (mg)
The results are shown in Figure 4 & discuss in the Table 1.
Figure 4:- Chromatogram obtained for Laboratory mixture of TAP and PARA Showing retention time for TAP – 
3.726 min. and PARA – 6.466 min.
Table 1 : Analysis of Physical Laboratory mixture for TAP and PARA
Sr. No. Wt. of Std (mg) Wt. of Sample Peak area of Std. Peak area of Sample % Drug estimated
TAP PARA TAP PARA TAP PARA TAP PARA TAP PARA
1 29.97 65.14 29.04 65.11 505709 398474 498523 395865 101.8 101.4
2 29.06 65.09 29.16 65.23 504844 397458 503265 386521 100.6 99.84
3 29.14 65.04 29.21 65.08 506228 395025 504563 394526 101.2 100.5
Mean 101.2 100.4
±SD 0.612 0.7830
% RSD 0.59 0.776
2.8 Analysis of marketed formulation
2.8.1 Preparation of sample solution:  Weigh accurately 20 tablets and calculate the average weight then crushed the 
tablets into fine powder. Transfer 5 tablets into 500.0 mL volumetric flask and sonicate it for 15-20 Min with intermittent 
shaking and make up the volume with diluent. Centrifuge, the portion of solution at 3000 rpm for 10 Min to get a clear  
solution. (Conc. of TAP is 500.0 µg/mL and Conc. of PARA is 3250.0 µg/mL) 
Pipette out 2.0 mL of above solution in 50.0 mL volumetric flask & make up the volume with water. Filter the 
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above solution through 0.45 µm Teflon filer paper. (Conc. of TAP is 20.0 µg/mL and Conc. of PARA is 130.0 µg/mL). 
The chromatograms were recorded and the response i.e. peak area of major peaks were measured. The % Label 
Claims of TAP and PARA were calculated by comparing a sample peak with that of standard.
a) Amount of TAP HCl equivalent to TAP in mg per tablet was calculated by using following formula 
  Aspl        Wstd       4      500     50    %P     221.34
% Label claim =  ------ -- ×--------×-----×-------×-----×------×---------× A
                              Astd        100       50    Wspl     2     100     257.8
b) Amount of PARA in mg per tablet was calculated by using following formula
                              Aspl     Wstd         10       500        50        %P 
 % Label claim = ------- ×------- × ------×---------×-------×--------×A
                              Astd      100         50    Wspl         2        100 
Where,
Asp1 = Area count for Sample solution.; Astd = Area count for Standard solution.; Wstd = Weight of Standard in mg;  
Wspl = Weight of Sample in mg; LC = Label claim.; A =Average weight of tablet in mg; %P = Potency of Standard; 
221.34 = Molecular wt of TAP; 257.8 = Molecular wt of TAP HCl
The results are shown in Figure 5 & discuss in the Table 2.
Figure 5: Chromatogram obtained by Marketed Formulation of TAP and PARA showing retention time for TAP 
6.593 min & PARA 3.754 min 
Table 2 : Analysis of Marketed Formulation
Std weight(mg) Sample
weight (mg)
Area of Std Area of Sample % Assay
TAP PARA TAP PARA TAP PARA TAP PARA
29.15 65.05
2594.12
522182 4024283
521938 402983 101.3 101.7
2594.30 521655 402088 100.8 101.9
2594.52 522192 402522 101.4 99
Mean
± S.D.
% RS.D.
101.1 101.4
0.321 1.216
0.317 1.205
2.9 Optimization of chromatographic condition for estimation of drugs: The mobile phase was allowed to equilibrate 
with stationary phase until steady baseline was obtained. The standard solution containing mixture of TAP & PARA was run 
and different individual solvents as well as combinations of solvents have been tried to get a good separation and stable 
peak. Each mobile phase was filtered through 0.45 µm Teflon filter.
Finally, the optimal composition of the mobile phase, KH2PO4 buffer with 1.0 mL of TEA (pH adjusted to 3.0 with 
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OPA): ACN: MeOH in the ratio of 75:20:05 was selected. It gave high resolution of TAP and PARA with minimal tailing. 
2.10 Calibration curves for tap & para: Aliquots of TAP and PARA standard solutions were transferred into 100.0 mL 
volumetric flasks. The volume was adjusted to the mark with diluent to obtain concentrations in the range of 80%- 120%. 
The graph of peak area obtained verses respective concentration was plotted. The mean area was calculated. 
2.11  System suitability  test:  System suitability  is  a  pharmacopoeial  requirement  and  is  used  to  verify,  whether  the  
resolution and reproducibility of the chromatographic system are adequate for analysis to be carried out. It is performed to  
ensure that the system is operating properly and read to deliver results with acceptable accuracy and precision. The tests  
were performed by collecting data from five replicate injections of standard solutions.
2.12 Validation parameters15-17: 
i. Linearity : A series of standard preparations of TAP and PARA working standard were prepared over a range of 50% to 
120% of the working standard concentration of TAP and PARA in TAP and PARA tablet. Since the working standard  
concentration was 20 µg/mL and 130 µg/mL for TAP and PARA, the proposed ranges were about 11.89 µg/mL to 28.55 
µg/mL and 64.95 µg/mL to 155.90 µg/mL for TAP and PARA respectively.  Plot a graph of peak response against  
concentration. Determine the correlation coefficient.
ii. Accuracy: Placebo of TAP and PARA tablet was spiked with TAP and PARA drug corresponding to level 80, 100 and  
120 % of label claim in triplicate (in total nine determination).  Acceptance Criteria: Mean recovery should be in the 
range of 98-102%. The Relative Standard Deviation should not be more than 2.0%
iii. Precision  :Precision  of  an  analytical  method is  the  degree  of  agreement  among individual  test  results  when  the 
procedure is applied repeatedly to multiple samplings of a homogenous sample. Precision of an analytical method is 
usually expressed as standard deviation or relative standard deviation. 
iv. Ruggedness :It is the degree of reproducibility of the test result obtained by analysis of samples, under a variety of  
condition such as different lab, analyst, instrument, lots of reagents, elapsed time, different  time, temp, days etc . Six 
sample solution of same lot (as used in 3.2) of TAP & PARA tablets were analysed by different analyst using same  
make of different HPLC column, on different day & HPLC as per described method. 
v. Specificity (Force Degradation Study): Specificity is an ability to measures accurately and specifically the analyte of 
interest in the other components that may be expected to be present in the sample matrix. The result was shown in the  
Table 3.
Table 3 : Forced Degradation Study
Sr. No Degradation Weight of sample Stress condition
1. Acid degradation 2594.60 1M HCL (water) 5 ml, Heat at 65°C for 60 Min
2. Base degradation 2594.62 1M NaOH (water) 5 ml, Heat at 65°C for 60 Min 
3. Peroxide degradation 2594.65 3% H2O2 (water) 5 ml Heat at 65°C for 60 Min 
4. Photo degradation 2594.58 24 hours in UV chamber
5. Thermal degradation 1807.5 50°C for 24 hours
vi. Robustness:It  is  the measure of capacity of  the method to remain unaffected by small  but  deliberate variation in  
method parameter and provides an indication of its reliability under normal usage.
Standard  solution,  placebo  solution  and  sample  solution  in  triplicate  were  prepared.  The  sample  along  with 
standard and placebo were injected under different chromatographic conditions as shown below.
Ø Changes in organic phase composition. (±2%)
Ø Changes in column oven temperature. (±5°C)
Ø Changes in flow rate. (±0.20 ml/min)
2.13 Stability of analytical solution: Prepare standard and sample solutions as per the method and inject one standard and 
sample preparation initially at 0 hour and after specified time-intervals i.e. after 4 hours, 8 hours and 12 hours. Monitor the 
pattern of chromatogram at the pre-determined intervals and compare it against the initial pattern. Calculate the assay at  
each time interval. The stability of analytical solution is checked for drugs upto 12 hours. 
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3. Results and Disscussion
3.1Optimization of chromatographic condition for estimation of drug
Column                               :  Inertsil ODS (250×4.6 mm, 5 µ) 
Flow Rate                           :  1.2 mL/Min
Wavelength                         :  220 nm
Injection Volume                 :  20.0 µL
Column Oven Temperature :  30ºC
Run Time                             :  12 Min
Mobile Phase                       :  Buffer (1mL TEA) : ACN : MeOH (75:20:5 v/v/v)
pH                                        : 3.0 
Proper peak shape was observed for both TAP & PARA and system suitability parameters was observed within the 
limits. The result was shown in the Figure 6.
 Figure 6: Chromatogram obtained by using Phosphate buffer pH 3.0
3.2 System Suitability Test:  % RSD of five replicate injections of TAP & PARA was found to be 0.08 & 0.07 respectively. 
Theoretical plates for TAP & PARA was found to be 7478.6 & 7072.8 respectively. Tailing factor for TAP & PARA was  
found to be 1.141& 1.097 respectively This indicates that system suitability parameters for proposed method were found to  
be within the limit. The result was shown in the Figure 7.
Figure 7: Chromatogram for System Suitability 
3.3 Validation Parameters 
i. Linearity  :Linearity  regression  coefficients  were  observed  0.9991 & 0.9996 for  TAP & PARA respectively.  The 
observed values were within the acceptance criteria for the Linearity of the method.  Therefore, the proposed HPLC 
method for the determination of TAP and PARA in a tablet was found to be linear. The linearity was shown in the 
figure 8 & 9.
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Figure 8 : Calibration Curve for TAP
 Figure 9: Calibration Curve for PARA
ii. Accuracy :% mean recoveries were found 99.98 % with % RSD 1.259 for TAP & 100.0 with % RSD 0.8625 for  
PARA. This showed that, the proposed HPLC method for the determination of TAP and PARA in a tablet was found to 
be accurate. The result was shown in the figure10.
Figure 10 : Chromatogram of Accuracy
iii. Precision
System precision : % RSD of system precision was observed 0.080 for TAP & 0.069 for PARA. The observed values were 
within  the  acceptance  criteria  for  System  Precision study.  This  showed  that,  the  proposed  HPLC  method  for  the 
determination of TAP and PARA in a tablet was found to be precise. The result was shown in the figure11.
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Figure11 :Chromatogram of system precision
Method Precision (Intraday precision):   % RSD of method precision was found 0.084 and 0.384 for TAP and PARA 
respectively. The observed values were within the acceptance criteria for Intraday Precision study .Therefore, the proposed 
HPLC method for the determination of TAP and PARA in a tablet was found to be precise. The result was shown in the 
Figure 12.
Figure 12 : Chromatogram of Intraday Precision
iv. Ruggedness: % RSD was observed 0.421 and 1.019 for TAP and PARA respectively. The observed values were within 
the acceptance criteria for Ruggedness study.  This showed that, the proposed HPLC method for the determination of 
TAP and PARA in a tablet was found to be rugged. The result was shown in the Figure13.
Figure 13 : Chromatogram of Ruggedness 
v. Specificity :% degradation for TAP was observed 16.5 % in base & that of PARA was 19.1% in acid. This showed that, 
the proposed HPLC method for the determination of TAP and PARA in a tablet was found to be specific. The result was 
shown in the Figure14 & 15 discuss in the Table 4.
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Figure14 : Chromatogram of acid stressed degradation of drug product. 
Figure15 : Chromatogram of alkali stressed degradation of drug product
Table 4: Results of Forced Degradation of Sample
Sr 
No Amount in % w/w
Wt. Taken 
in mg
Area of 
TAP
Area of 
PARA
% LC 
of TAP
%LC of 
PARA
% 
degradation
%  
degradation
1 Control sample 2594.0 51981 40068 101.7 100.5 ... ----
2
Acid degradation 
sample 2594.2 51103 29233 101.2 80.6 ... 19.1
3
Base  degradation 
sample 2594.1 39452 40895 85.2 100.1 16.5 ----
4
Peroxide 
degradation sample 2594.2 51569 39256 100.8 99.4 --- ----
5
Photo Degradation 
Sample 2594.2 51458 39856 100.3 99.7 ... ----
vi. Robustness :% R.S.D. of six replicate injections (Low temp, High temp) was observed 0.6836, 0.827 for TAP & 
0.700 , 0.292 for PARA .% R.S.D. of six replicate injections (Low temp, High temp) was within the acceptance criteria. 
This showed that, the proposed HPLC method for the determination of TAP & PARA in a tablet was found to be robust.
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4. Conclusion
The method provides  selective quantification of TAP and PARA without interference from blank affirming its 
stability- indicating nature. The proposed method is highly sensitive, reproducible, specific and rapid. The method was  
completely validated showing satisfactory data for all the method validation parameters tested. The developed method was 
robust  in  the  separation  and  quantification  of  TAP and  PARA.  This  method  can  be  used  for  the  routine  analysis  of  
production samples. The information presented herein could be very useful for quality monitoring of bulk samples and as  
well employed to check the quality during stability studies.
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